GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Honz Pharmaceutical Co Ltd (SZSE:300086) » Definitions » Days Sales Outstanding

Honz Pharmaceutical Co (SZSE:300086) Days Sales Outstanding : 103.05 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Honz Pharmaceutical Co Days Sales Outstanding?

Honz Pharmaceutical Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥118.3 Mil. Honz Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ¥104.7 Mil. Hence, Honz Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 103.05.

The historical rank and industry rank for Honz Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

SZSE:300086' s Days Sales Outstanding Range Over the Past 10 Years
Min: 23.08   Med: 48.86   Max: 75.12
Current: 41.85

During the past 13 years, Honz Pharmaceutical Co's highest Days Sales Outstanding was 75.12. The lowest was 23.08. And the median was 48.86.

SZSE:300086's Days Sales Outstanding is ranked better than
78.11% of 996 companies
in the Drug Manufacturers industry
Industry Median: 71.41 vs SZSE:300086: 41.85

Honz Pharmaceutical Co's Days Sales Outstanding increased from Mar. 2023 (31.68) to Mar. 2024 (103.05).


Honz Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Honz Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Honz Pharmaceutical Co Days Sales Outstanding Chart

Honz Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.83 48.81 64.37 75.12 51.08

Honz Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.68 29.29 37.39 28.77 103.05

Competitive Comparison of Honz Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Honz Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Honz Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Honz Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Honz Pharmaceutical Co's Days Sales Outstanding falls into.



Honz Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Honz Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (71.131 + 135.875) / 2 ) / 739.57*365
=103.503 / 739.57*365
=51.08

Honz Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (135.875 + 100.694) / 2 ) / 104.742*365 / 4
=118.2845 / 104.742*365 / 4
=103.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Honz Pharmaceutical Co  (SZSE:300086) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Honz Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Honz Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Honz Pharmaceutical Co (SZSE:300086) Business Description

Traded in Other Exchanges
N/A
Address
No. 69 Xianlie Zhonglu, 2601 26/F Dongshan Plaza, GuangDong,Province, Guangzhou, CHN, 510095
Honz Pharmaceutical Co Ltd is engaged in providing medicines for children. The company's practice in this sector mainly involves the research and development, manufacturing and sales of pediatric medicines. It has automated and intelligent manufacturing bases in Hainan, Beijing, Hebei, Liaoning, and Guangdong.
Executives
Wang Chun Ying Supervisors
Rui Shou Hong Director
Hong Jiang You Directors, executives
Hong Zhi Hui Director
He Zi Qun Supervisors
Hong Li Ping Directors, executives
Hong Jiang Tao Director
Liu Hui Liang Executives
Hu Fei Hong Director
Li Ping Independent director
Fu Lin Jun Director

Honz Pharmaceutical Co (SZSE:300086) Headlines

No Headlines